Litcius/Paper detail

<i>Lentinus squarrosulus</i> Mont. Mushroom: Molecular Identification, In vitro Anti-Diabetic, Anti-Obesity, and Cytotoxicity Assessment

Oyindamola O. Abiodun, Adenike Martha ALEGE, Precious U. Ezurike, Abraham O. Nkumah, Oluwatosin ADELOWO, Tolulope Aderinola OKE

2021Turkish Journal of Pharmaceutical Sciences10 citationsDOIOpen Access PDF

Abstract

Objectives: Mushrooms are fungi with nutritional and health benefits. Lentinus squarrosulus Mont., an edible fungus, has traditional usage and relevance in local therapy for managing metabolic diseases. In that view, this study aimed to evaluate the in vitro anti-obesity, anti-diabetic, and cytotoxic potential of the chloroform/methanol extract (CME) and aqueous extract (AE) of the mushroom. Materials and Methods: L. squarrosulus was identified using molecular biology tools. The CME and AE were obtained sequentially and, then, subjected to -amylase, -glucosidase, and lipase inhibitory enzyme assays as well as total phenolic content (TPC) and flavonoid content (TFC) estimations. The cytotoxic potential of extract fractions of L. squarrosulus was assessed using the brine shrimp lethality assay.

Topics & Concepts

MushroomFood scienceTraditional medicineLipaseIC50BiochemistryChemistryIn vitroEnzymeMedicineFungal Biology and ApplicationsPhytochemistry and Bioactivity StudiesPhytochemicals and Antioxidant Activities
<i>Lentinus squarrosulus</i> Mont. Mushroom: Molecular Identification, In vitro Anti-Diabetic, Anti-Obesity, and Cytotoxicity Assessment | Litcius